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Purpose: To evaluate the relationship among single nucleotide polymorphisms (SNPs) in steroidogenesis enzyme genes,
serum levels of sex steroids, and high myopia in Taiwanese male and female populations.
Methods: A campus-based sample of 283 cases (145 males and 138 females) with high myopia and 280 controls (144
males and 136 females) with low myopia or emmetropia was studied. Estradiol, progesterone, and testosterone levels were
determined using enzyme-linked immunosorbent assay kits. We genotyped six SNPs within five steroidogenesis enzyme
genes  (17  alpha-hydroxylase/17,20  lyase  [CYP17A1],  3  beta-hydroxysteroid  dehydrogenase  [HSD3B1],  17  beta-
hydroxysteroid dehydrogenase 1 [HSD17B1], steroid-5-alpha-reductase, alpha polypeptide 2 [SRD5A2], and aromatase
[CYP19A1]) using polymerase chain reaction–restriction fragment length polymorphism methods. Student’s t-tests, χ2
tests, logistic regression, multifactor dimensionality reduction (MDR) methods, and ANOVA were used to determine
significance.
Results: An MDR analysis corroborated the synergistic genotype association and demonstrated that synergistic interaction
between rs6203 (HSD3B1), rs10046 (CYP19A1), and sex might confer susceptibility to high myopia (p=0.019). In both
male and female subjects, levels of testosterone were significantly higher in cases than in controls; in male subjects, the
levels of estradiol were significantly higher and those of progesterone were significantly lower in cases (all p-values
<0.001). The rs605059 (HSD17B1), with sex-gene interaction, showed association with estradiol levels in males (p=0.035)
and testosterone levels in females (p=0.027).
Conclusions: Testosterone levels correlate with high myopia, and interaction of steroidogenesis enzyme genes and sex
may be a modulating factor in sex hormone metabolism and high-myopia risk.
Myopia is the most common eye disorder in Taiwan and
around the world. A refractive error in excess of −6 diopters
(D), defined as high myopia, is also termed “pathological
myopia”  due  to  its  associated  potential  complications,
including  cataracts,  glaucoma,  macular  degeneration,  and
retinal  detachment,  which  can  lead  to  blindness.  Many
environmental  factors  [1,2]  have  been  reported  to  be
associated with myopia. Population, family, and twin studies
also have provided evidence for a genetic component to high
myopia [3-5]. According to a nationwide survey in Taiwan in
2000, girls have a higher prevalence and more severe myopia
progression  than  boys  [6].  Several  other  epidemiological
studies [7,8] have also shown similar results. In addition, the
female sex was reported to be independently associated with
faster myopia progression [9]. Because of sex differences, a
hormonal hypothesis has been postulated by a review article
examining  myopia  in  opposite-sex  twins  [10].  In  animal
models, sex differences were also demonstrated in chick eye
growth and experimental myopia [11]. It has also been shown
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that  myopia  progresses  quickly  in  childhood,  especially
around puberty [6-8,12]. These studies have demonstrated
that sex may be a modulating factor affecting myopia and have
suggested that the differential expression of sex hormones
may  be  as  well.  Knowledge  about  sex  differences  in  the
progression  of  myopia  and  about  the  pathophysiology
underlying those differences may enhance the accuracy and
effectiveness of clinical assessment and treatment of myopia.
With  a  remarkable  prevalence  of  high  myopia  and  a
homogenous genetic background, the Taiwanese population
would be the best candidate for genetic studies to find myopia
susceptibility genes, and approaches focusing on high myopia
may minimize the impact of environmental confounders.
Thinning of the sclera is a key feature of human myopia
development. Modulated by retinoscleral signals, the scleral
remodeling  mechanism  is  common  [13-16]  to  different
paradigms of myopia induction. It involves the regulation of
numerous gene products (mRNAs and proteins) [17-23] in the
extracellular matrix, such as collagens, proteoglycans, matrix
metalloproteinases  (MMPs),  and  tissue  inhibitors  of
metalloproteinases (TIMMPs). Sex steroids are present in all
tissues because they circulate through the blood; however,
their effects can be observed only in cells armed with the
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2297corresponding receptors [24]. Studies have demonstrated the
presence of androgen, estrogen, and/or progesterone receptors
in  various  ocular  tissues,  such  as  the  lacrimal  gland,
meibomian gland, lid, conjunctiva, cornea, iris/ciliary body,
lens,  retina/uvea,  retina/choroid,  and  retinal  pigment
epithelial  cells  [24-28].  Nevertheless,  both  the  levels  and
activities of these receptor proteins are regulated by hormones
in the blood, suggesting that the sex hormone axis may play
a role in the pathogenesis of certain ocular diseases.
Progesterone  and  estradiol  are  the  major  naturally
occurring human hormones in the groups of progestogens and
estrogens, respectively. Testosterone, a steroid hormone from
the  androgen  group,  is  the  principal  male  sex  hormone.
Steroids  have  been  reported  to  change  the  biochemical
characteristics  of  the  iris/ciliary  body,  aqueous  outflow
pathway, and sclera in the rabbit eye [29]. In humans, estrogen
is a modulating factor of the biomechanical properties of the
cornea,  which  may  contribute  to  the  development  of
keratectasia after corneal refractive surgery [30]. Changes in
cornea thickness due to fluctuations in estrogen levels are
known to occur during the menstrual cycle [31] and pregnancy
[32]. Corneal curvature also changes during pregnancy [33].
Besides, steroidogenesis enzymes and sex steroids have been
proved to be related to ocular physiology and diseases [24,
34-42]. Hormonal balance has been hypothesized to be related
to the weakening of the collagenous tissue of the sclera [43].
However, no studies have been published to date regarding
the influence of these sex hormones on the sclera or clinical
myopia. Further research on this will be helpful to assess and
manage myopia.
Sex  steroids  such  as  estrogen  and
dehydroepiandrosterone (DHEA, belonging to the androgen
group) have been reported to regulate MMPs. Estrogen is
known to upregulate MMP-2 and/or MMP-9 in mouse and
human cells [26,44-46]. Depression of MMP-2 activity, on the
other hand, has been shown in the rat polycystic ovary (PCO)
induced by DHEA [47]. Because MMP-2 upregulation was
suggested  to  take  part  in  scleral  remodeling  in  myopia
development  [17,23],  and  because  sex  hormones  might
implicate  MMP-2  in  the  pathogenesis  of  myopia,  our
hypothesis is that genetic polymorphisms in steroidogenesis
enzyme genes may affect circulating sex steroid levels and
thus influence the risk of high myopia.
The progestogens, estrogens, and androgens are the three
major classes of sex steroids and are derivatives of cholesterol
(Figure 1; progestogens in orange boxes, estrogens in yellow
boxes, and androgens in blue boxes). The enzymes involved
in  the  biogenesis  of  sex  hormones  include  17  alpha-
hydroxylase/17,20 lyase (CYP17A1), 3 beta-hydroxysteroid
dehydrogenase  (HSD3B1),  17  beta-hydroxysteroid
dehydrogenase  1  (HSD17B1),  steroid-5-alpha-reductase,
alpha polypeptide 2 (SRD5A2), and aromatase (CYP19A1).
Several notable nonsynonymous SNPs or common SNPs with
functional effects have been reported in these genes, including
rs743572  (CYP17A1),  rs6203  (HSD3B1),  rs1047303
(HSD3B1), rs605059 (HSD17B1), rs523349 (SRD5A2), and
rs10046 (CYP19A1) [48-59]. rs743572 (CYP17A1) is located
in the 5′ UTR and rs10046 (CYP19A1) is located in the 3′
UTR, the rest of these SNPs are all in exon areas.
Herein, we report the first case-control study to assess the
relationship  among  genetic  variations  of  steroidogenesis
enzymes,  sex  hormone  levels  (including  progesterone,
estradiol, and testosterone), and high myopia.
METHODS
Ethics  statement:  The  study  was  approved  by  the  Ethics
Committees  of  the  National  Taiwan  University  Hospital,
Figure 1. Major pathways in sex steroid biosynthesis (progestogens in orange boxes, estrogens in yellow boxes, and androgens in blue boxes).
CYP11A1=cholesterol  desmolase,  CYP17A1=17  alpha-hydroxylase/17,20  lyase,  HSD3B=3  beta-hydroxysteroid  dehydrogenase,
HSD17B1=17 beta-hydroxysteroid dehydrogenase 1, CYP19A1=aromatase, SRD5A2=steroid-5-alpha-reductase, alpha polypeptide 2.
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Helsinki. All participants were informed about the nature of
the study and signed a written consent form before blood
withdrawal.
Subjects and clinical assessment: A total of 283 unrelated
high-myopia  cases  (145  males  and  138  females)  with
refractive errors in excess of −6 D in both eyes and 280
controls (144 males and 136 females) with refractive errors of
−2 D to 1 D in either eye were recruited from the National
Taiwan University for this campus-based control study. No
participant had ammetropia of more than 2 D or known ocular
diseases/insults that could predispose to myopia. All subjects
were  of  Han  Chinese  origin  and  were  similar  in  social
background.  Ocular  examination  included  objective
autorefraction and keratometry (KR-8100; Topcon, Tokyo,
Japan) and slit-lamp evaluation.
Measurement  of  hormone  levels:  Blood  samples  were
centrifuged at 805× g for 15 min at 4 °C, and serum was
separated and stored at −30 °C until analysis. Hormone levels
were  determined  using  an  enzyme-linked  immunosorbent
assay  (ELISA)  kit  (Diagnostic  Systems  Laboratories,  San
Antonio, TX) according to the manufacturer's instructions.
The Steroid ELISA is based on the principle of competitive
binding between steroids in the test specimen and steroid-
horseradish  peroxidase  (HRP)  conjugate  for  a  constant
amount of rabbit anti-steroid (progesterone, estradiol, and
testosterone). In the incubation, goat anti-rabbit IgG-coated
wells were incubated with standards (25 μl for progesterone
and estradiol, 10 μl for testosterone), controls, subject samples
(25 μl for progesterone and estradiol, 10 μl for testosterone),
100 μl steroid-HRP conjugate reagent, and 50 μl rabbit anti-
steroid hormone reagent at room temperature (18–25 °C) for
90 min. During the incubation, a fixed amount of HRP-labeled
steroid  hormone  competed  with  the  endogenous  steroid
hormone in the standard, sample, or quality control serum for
a fixed number of binding sites of the specific steroid hormone
antibody. Thus, the amount of steroid hormone peroxidase
conjugate immunologically bound to the well progressively
decreased  as  the  concentration  of  steroid  hormone  in  the
specimen increased. Unbound steroid hormone peroxidase
conjugate was then removed, and the wells were washed.
Next,  a  solution  of  H2O2/TMB  reagent  (100  μl  TMB  for
progesterone and testosterone, 200 μl H2O2/TMB only for
estradiol) was added and incubated at room temperature for
20 min, resulting in the development of blue color. The color
development was stopped with the addition of stop solution
(100 μl 1N HCl for progesterone and testosterone, 100 μl 3N
HCl only for estradiol) and the absorbance was measured
spectrophotometrically at 450 nm. Standards were assayed in
duplicate,  and  unknowns  were  assayed  in  triplicate.  The
results were expressed as ng/ml or pg/ml.
SNP  genotyping:  Genomic  DNA  was  extracted  from
participants’  peripheral  leukocytes  using  an  extraction  kit
(Qiagen  GmbH,  Hilden,  Germany).  To  analyze
polymorphisms  in  each  gene,  we  used  polymerase  chain
reaction–restriction  fragment  length  polymorphism  (PCR-
RFLP) methods to directly genotype the polymorphism. The
primers  for  amplifying  50  ng  of  genomic  DNA  were  as
follows: 5′-GCT AGG GTA AGC AGC AAG AG-3′ and 5′-
CAA  GGT  GAA  GAT  CAG  GGT  AG-3′  for  rs743572
(CYP17A1), 5′-GGC TTC CTG CTG GAA ATA GTG A-3′
and  5′-GCA  AAC  CAC  ATG  GTC  TTT  CCT  C-3′  for
rs6203  (HSD3B1),  5′-CAG  GCC  AAT  TTA  CAC  CTA
TCG-3′ and 5′-TCA AAC TAT GTG AAG GAA TGG A-3′
for rs1047303 (HSD3B1), 5′-CCT TCC ACC GCT TCT ACC
AAT A-3′ and 5′-CAG GGA CCA CAC AGA CCC AG-3′
for rs605059 (HSD17B1), 5′-AGG ATT TGG AGC TGC
TGA GAG C-3′ and 5′-GAC GGT ACT TCT GGG CCT CTT
CTA C-3′ for rs523349 (SRD5A2), and 5′-ACT ACT GAT
GAG AAA TGC TCC AGA CT-3′ and 5′-GGT TCC TTA
TAG GTA CTT TCA GCC A-3′ for rs10046 (CYP19A1). The
PCR reactions were performed in 25-μl aliquots containing 20
pmole  of  each  primer,  1×  reaction  buffer,  100  µM
deoxynucleotide triphosphates, and 1 unit of Taq polymerase;
a  PCR  system  9700  thermocycler  (Applied  Biosystems,
Foster City, CA) was used for cycling. The temperatures used
during PCR were as follows: for rs743572, 95 °C for 2 min,
followed by 30 cycles of 95 °C for 1 min, 57 °C for 1 min,
and 72 °C for 1 min, with a final extension at 72 °C for 10
min; for rs6203 and rs605059, 95 °C for 2 min, followed by
30 cycles of 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30
s, with a final extension at 72 °C for 10 min; for rs1047303,
95 °C for 2 min, followed by 40 cycles of 95 °C for 30 s, 50 °C
for 30 s, and 72 °C for 30 s, with a final extension at 72 °C for
10 min; and for rs523349 and rs10046, 95 °C for 2 min,
followed by 30 cycles of 95 °C for 30 s, 52 °C for 30 s, and
72 °C for 30 s, with a final extension at 72 °C for 10 min.
Aliquots of PCR products were digested with the following
restriction enzymes and conditions: MspA1I for rs743572 at
37 °C for 3 h, BglI for rs6203 at 37 °C overnight, DrdI for
rs1047303 at 37 °C overnight, BtsI for rs605059 at 55 °C
overnight, HpyCH4V for rs523349 at 37 °C overnight, and
BsrCI for rs10046 at 65 °C overnight, in reaction mixtures
containing  10  μl  of  PCR  product,  digestion  buffer,  BSA
(BSA),  and  5  units  of  restriction  enzyme  (New  England
Biolabs,  Ipswich,  MA).  The  digested  fragments  were
visualized on 4% agarose gel with ethidium bromide staining
to identify the base pair change. To exclude the possibility of
introducing  PCR  error  and  miscutting  of  the  restriction
enzyme, all steps were repeated twice. For equivocal results,
we double-checked with either repeating the experiments or
directly sequencing the PCR products using dye terminator
chemistry (BigDye Terminator version 3.1 on a model 3730
Genetic Analyzer; Applied Biosystems).
Statistical analyses: SAS version 9.1 (SAS, Inc., Cary, NC)
was used for all statistical comparisons. Comparisons of age,
refractive status, and hormone levels between the case and
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Genotypes were assessed for Hardy–Weinberg equilibrium
(HWE), and allele frequencies were compared between cases
and controls using χ2 tests. Odds ratios (ORs) for specific
genotypes and 95% confidence intervals (CIs) were calculated
using  logistic  regression  analyses  with  the  wild  type
genotypes as references. Synergistic analysis was evaluated
by pairwise modification of genotypic associations through
logistic regression. Global and genotypic-specific p-values
were  reported.  The  multifactor  dimensionality  reduction
(MDR) method [60,61] with version 1.1.0 of the open-source
MDR  software  package  (Dartmouth  Medical  School,
Hanover, NH) was used to search for the most potential gene-
gene interaction models. MDR tests all possible multilocus
genotype  combinations  and  reports  a  combination  that
provides the best classification [62]. The final models with
relatively highest prediction accuracy for single to four-way
interactions are selected for cross-validation. This method,
which is a nonparametric and model-free approach, combines
cross-validation  and  permutation-testing  procedures  to
minimize false positives caused by multiple testing and has
performed  well  across  many  genetic  simulation  scenarios
where purely epistatic relationships existed between status
and variables without main effects [63]. True-positive models
possess estimated testing accuracy of 50% or more cross-
validation  consistency.  ANOVA  (ANOVA)  including  six
polymorphisms and sex was performed with the general linear
models  (GLM)  procedure  to  determine  the  sources  of
variation for hormone levels, and F tests computed from the
type III sums of squares reported the effect of an independent
variable after adjustment for all other independent variables
included  in  the  model.  Two-way  interaction  of  each
polymorphism and sex was also analyzed. Another ANOVA
compared  between-group  hormone  levels  for  different
genotypes of steroidogenesis enzyme genes. Data from males
and females were also analyzed separately.
RESULTS
Subjects: Our study consisted of 283 high-myopia cases (145
males and 138 females; average age 18.8±0.8 years [mean
±standard deviation]; average spherical equivalent −8.2±1.7
D for right eyes, −8.0±1.8 D for left eyes) and 280 emmetropia
or low-myopia controls (144 males and 136 femals; average
age  19.4±2.4  years  [mean±standard  deviation];  average
spherical equivalent −0.8±0.8 D for right eyes, −0.7±0.8 D for
left eyes; Table 1).
TABLE 1. BASELINE CHARACTERISTICS
All subjects  
Variable Case (n=283) Control (n=280) p-value
Age (years) 18.8±0.8 19.4±2.4 <0.001
Male (%) 148 (51.0) 147 (51.4) 0.930
SEM of right eye (D) −8.2±1.7 −0.8±0.8 <0.001
SEM of left eye (D) −8.0±1.8 −0.7±0.8 <0.001
Progesterone (ng/ml) 3.7±3.8 5.2±6.6 0.008
Estradiol (pg/ml) 34.8±22.1 35.1±30.5 0.895
Testosterone (ng/ml) 4.1±2.8 3.4±2.5 <0.001
Male subjects
  Case (n=145) Control (n=144)  
Age (years) 18.8±1.0 19.2±2.1 0.019
SEM of right eye (D) −8.3±1.6 −0.9±0.8 <0.001
SEM of left eye (D) −8.1±1.5 −0.8±0.8 <0.001
Progesterone (ng/ml) 2.6±1.7 3.9±4.0 <0.001
Estradiol (pg/ml) 26.6±11.9 20.9±15.2 <0.001
Testosterone (ng/ml) 6.3±2.1 5.4±1.5 <0.001
Female subjects
  Case (n=138) Control (n=136)  
Age (years) 18.8±0.6 19.6±2.6 <0.001
SEM of right eye (D) −8.0±1.7 −0.7±0.8 <0.001
SEM of left eye (D) −7.9±2.1 −0.7±0.7 <0.001
Progesterone (ng/ml) 4.8±4.9 6.6±8.4 0.031
Estradiol (pg/ml) 43.4±26.7 50.2±35.4 0.074
Testosterone (ng/ml) 1.9±1.3 1.2±0.9 <0.001
Data are reported as mean±standard deviation. SE=spherical equivalent; D=diopter.
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lower  and  levels  of  estradiol  and  testosterone  were
significantly higher in the cases than in the controls for male
subjects  (all  p-values  <0.001;  Table  1).  The  level  of
testosterone was also significantly higher in the cases than in
the controls for female subjects (p<0.001; Table 1).
Genotype association: Although no statistically significant
deviation from HWE was noted for the controls, the genotypes
of  all  SNPs  between  the  cases  and  controls  were  not
statistically different (all p-values >0.05; Table 2). Pairwise
stratified  analyses  conducted  separately  among  male  and
female  subjects  for  all  six  SNPs  (rs743572  [CYP17A1],
rs6203  [HSD3B1],  rs1047303  [HSD3B1],  rs605059
[HSD17B1], rs523349 [SRD5A2], and rs10046 [CYP19A1]
were indicated as SNP1–6, respectively) were used to evaluate
synergistic  modification  of  association  with  logistic
regression. All the significant results are shown in Table 3.
Among male study subjects, SNP6-SNP2 and SNP3-SNP4
combinations showed significant modification of genotypic
risks for myopia in both global and specific tests. In the SNP6-
AG subgroup, the TC genotype in SNP2 was associated with
a high risk of myopia (OR=2.38 [1.17–4.83], p-value=0.017);
in the SNP4-GA subgroup, SNP3-AC was associated with a
higher  risk  (OR=4.32  [1.37–13.61],  p-value=0.013).
Meanwhile, these combinations were related to a protective
effect  among  female  subjects  (OR=0.40  [0.19–0.81],  p-
value=0.011  and  OR=0.57  [0.21–1.50],  p-value=0.253,
respectively).  Among  female  subjects,  SNP2-TC  was
associated with a significant risk (OR=2.88 [1.05–7.88], p-
value=0.04) in the SNP6-AA subgroup, and SNP2-CC was
associated with a protective effect (OR=0.26 [0.08–0.88], p-
value=0.03) in the SNP6-AG subgroup; however, there were
no  significant  association  among  male  subjects  (OR=0.96
[0.39–2.37],  p-value=0.929  and  OR=0.42  [0.12–1.46],  p-
value=0.173,  respectively).  Table  4  summarizes  the  best
interaction models of seven independent variables (including
these six SNPs and sex) in relation to high myopia obtained
from the MDR analysis. Consistent with synergistic genotypic
association, among all two-factor combinations, the model
composed of rs6203 (HSD3B1) and rs10046 (CYP19A1) was
the  best  attribute  for  predicting  high-myopia  risk,  though
without  statistical  significance  (testing  accuracy,  50.6%;
p=0.422;cross-validation  consistency,  7/10;  p=0.429).  The
best interaction model of all combinations was a three-factor
model composed of rs6203 (HSD3B1), rs10046 (CYP19A1),
and sex (testing accuracy, 57.5%; p=0.019; cross-validation
consistency, 10/10; p=0.07).
For all hormones tested, sex as an independent variable
was significantly associated with variation, with p<0.001 in
all cases (Table 5). The results of ANOVA that included a
gene-sex interaction term as an independent variable found
that the rs605059 (HSD17B1) genotype-sex interaction term
was  significant  (Table  5).  In  the  male  subjects,  genetic
variants  of  rs605059  (HSD17B1)  showed  between-group
TABLE 2. ASSOCIATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS IN SEX STEROIDOGENESIS ENZYME GENES AND HIGH MYOPIA RISK AND HARDY–WEINBERG EQUILIBRIUM TEST.
    HigKP\RSLD
 
HWE AssociatLRQUHVXOWV
 
Gene SNP Case
(n=283)
Control
(n=280)
p-value p-value OR (95% CI) p-value* OR (95% CI)*
CYP17A1 rs743572     1.000 0.608   0.351  
  GG 82 92     1.00 (reference)   1.00 (reference)
  GA 147 137     1.20 (0.83–1.76)   1.33 (0.90–1.95)
  AA 54 51     1.19 (0.73–1.93)   1.26 (0.77–2.06)
HSD3B1 rs6203     0.590 0.939   0.887  
  TT 115 113     1.00 (reference)   1.00 (reference)
  TC 138 133     1.02 (0.72–1.45)   1.00 (0.70–1.44)
  CC 30 34     0.87 (0.50–1.51)   0.89 (0.50–1.57)
HSD3B1 rs1047303     0.620 0.922   0.808  
  AA 236 239     1.00 (reference)   1.00 (reference)
  AC 46 40     1.16 (0.74–1.85)   1.18 (0.73–1.89)
  CC 1 1     1.01 (0.06–16.29)   0.82 (0.05–13.34)
HSD17B1 rs605059     0.359 0.809   0.821  
  GG 87 76     1.00 (reference)   1.00 (reference)
  GA 140 147     0.83 (0.57–1.22)   0.88 (0.60–1.31)
  AA 56 57     0.86 (0.53–1.39)   0.89 (0.55–1.45)
SRD5A2 rs523349     0.386 0.776   0.596  
  GG 97 99     1.00 (reference)   1.00 (reference)
  GC 141 129     1.12 (0.77–1.61)   1.17 (0.81–1.71)
  CC 45 52     0.88 (0.54–1.44)   0.91 (0.55–1.49)
CYP19A1 rs10046     0.983 0.799   0.678  
  AA 80 87     1.00 (reference)   1.00 (reference)
  AG 151 138     1.19 (0.81–1.74)   1.22 (0.83–1.80)
  GG 52 55     1.03 (0.63–1.67)   1.22 (0.66–1.84)
SNP=single nucleotide polymorphism; HWE=Hardy–Weinberg equilibrium test (conducted among controls); OR=odds ratio.
*Adjusted for sex and age.
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female  subjects,  genetic  variants  of  rs605059  (HSD17B1)
showed  between-group  differences  in  testosterone  levels
(p=0.027; Table 7).
Our results reveal that synergistic interaction of rs6203
(HSD3B1),  rs10046  (CYP19A1),  and  sex  may  confer
susceptibility to high myopia; testosterone levels for either sex
correlate  significantly  with  high  myopia;  and  rs605059
(HSD17B1)  interacting  with  sex-related  factors  may  be
associated  with  circulating  sex  hormone  levels  in  high
myopia.
DISCUSSION
To our knowledge, this is the first study that describes the
relationship  between  polymorphisms  in  steroidogenesis
enzyme genes and high-myopia risk and their correlations
with serum sex hormone levels. The principle findings of this
study are the identification of (1) the combination of rs6203
(HSD3B1),  rs10046  (CYP19A1),  and  sex  may  confer
susceptibility to high myopia; (2) significant differences in all
progesterone, estradiol, and testosterone levels between high-
myopia cases and controls in males and significant differences
in testosterone levels between high-myopia cases and controls
in females; (3) an association between rs605059 (HSD17B1)
and serum estradiol levels in males and serum testosterone
levels  in  females;  and  (4)  sexual  dimorphism  of  these
associations, which suggests a sex-gene interaction.
SNP information was obtained from reviewing papers
[48-59] and from GenBank. We validated the presence of six
common  SNPs  in  our  study.  A  comparison  with  four
populations  from  the  HapMap  database  (743572,6203,
1047303,605059,523349,  and  10046;  accessed  October  1,
TABLE 3. PAIRWISE STRATIFIED ANALYSIS OF SYNERGISTIC GENOTYPIC ASSOCIATION.
Variable Male Female
SNP6 SNP2 OR (95% CI) p-value p-value OR (95% CI) p-value p-value
AA TT 1.00 (Reference)   0.833 1.00 (Reference)   0.113
  TC 0.96 (0.39–2.37) 0.929   2.88 (1.05–7.88) 0.040  
  CC 1.40 (0.39–5.08) 0.609   1.44 (0.31–6.62) 0.639  
AG TT 1.00 (Reference)   0.007 1.00 (Reference)   0.015
  TC 2.38 (1.17–4.83) 0.017   0.40 (0.19–0.81) 0.011  
  CC 0.42 (0.12–1.46) 0.173   0.26 (0.08–0.88) 0.030  
GG TT 1.00 (Reference)   0.207 1.00 (Reference)   0.829
  TC 0.60 (0.18–2.00) 0.406   0.71 (0.23–2.15) 0.541  
  CC 3.00 (0.48–18.60) 0.238   -    
SNP4 SNP3 OR (95% CI) p-valuea p-valueb OR (95% CI) p-valuea p-valueb
GG AA 1.00 (Reference)   0.821 1.00 (Reference)   0.609
  AC 0.73 (0.27–1.97) 0.821   0.71 (0.19–2.67) 0.609  
  CC - -   - -  
GA AA 1.00 (Reference) 0.013 1.00 (Reference) 0.253
  AC 4.32 (1.37–13.61) 0.013   0.57 (0.21–1.50) 0.253  
  CC - -   - -  
AA AA 1.00 (Reference)   0.391 1.00 (Reference)   0.835
  AC 3.38 (0.59–19.21) 0.391   1.19 (0.24–5.84) 0.835  
  CC - -   - -  
        SNP2=rs6203 (HSD3B1); SNP3=rs1047303 (HSD3B1); SNP4=rs605059 (HSD17B1); SNP6=rs10046 (CYP19A1). aSpecific
        p-value. bGlobal p-value.
TABLE 4. SUMMARY OF MULTIFACTOR   DIMENSIONALITY   REDUCTION (MDR) ANALYSIS.
  Testing results 10-fold cross-validation
Factors in the best model Accuracy (%) p-valuea Consistency p-valuea
6 46.0 0.900 3/10 1.000
2, 6 50.6 0.424 7/10 0.429
2, 6. 7 57.5 0.019 10/10 0.070
1, 2, 4, 6 46.6 0.833 5/10 0836
        Factors: 1. SNP1: rs743572 (CYP17A1); 2. SNP2: rs6203 (HSD3B1); 3. SNP3: rs1047303 (HSD3B1); 4. SNP4: rs605059
        (HSD17B1); 5. SNP5: rs523349 (SRD5A2); 6. SNP6: rs10046 (CYP19A1); 7. Gender. MDR searches through all possible
        interaction combinations among independent variables (single factor to four-factor interaction models in this study) and reports
        a combination that provide the best fitness in each model. aEmpirical p-values were calculated by permutation analysis.
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a a b b2009) revealed significant differences in allele frequencies
between Taiwanese controls and both Utah, United States,
residents  with  European  ancestry  (CEU)  and  the  Yoruba
population in Ibadan, Nigeria (YRI; p<0.001; Table 8). The
between-population differences noted here may help explain
the well known differences in serum hormone levels and the
prevalence of hormone-related diseases between Asian and
Caucasian  populations  [64,65].  A  lack  of  deviation  from
HWE  among  controls  (Table  2)  indicated  that  population
stratification or genotyping errors are not likely. As the first
study investigating an association between polymorphisms in
steroidogenesis  enzyme  genes  and  high-myopia  risk,  this
study did not observe statistically significant associations in
any single variant. However, it is conceivable that particular
combinations of multiple variants may confer an enhanced
susceptibility  to  high  myopia.  Both  stratified  analysis  of
genotypic association (parametric) and MDR analysis (non-
parametric)  confirmed  a  synergistic  interaction  among
rs6203  (HSD3B1),  rs10046  (CYP19A1),  and  sex.  The
HSD3B gene family has two genes and five pseudogenes, all
of which map to chromosome 1p13 [66-68]. The HSD3B1
gene  encodes  the  type  I  enzyme,  which  is  exclusively
expressed  in  the  placenta  and  peripheral  tissues,  such  as
prostate, breast, and skin. The HSD3B2 gene encodes the type
II  enzyme,  which  is  predominantly  expressed  in  classical
steroidogenic tissues, namely the adrenals, testis, and ovary
[68-71]. 3β-hydrosteroid dehydrogenases (HSD3B1) catalyze
several reactions in the androgen pathway (Figure 1), leading
to production of androstenedione and testosterone. They also
catalyze the production of progesterone from pregnenolone.
Cytochrome  P-450  19A1  (CYP19A1),  located  on
chromosome 15, codes for aromatase, which is involved in the
rate-limiting  step  in  estrogen  production.  It  is  mainly
expressed in the ovarian granulose cells; however, aromatase
is  also  expressed  in  several  other  tissues,  including  fat,
placenta,  breast,  central  nervous  system,  skin,  and  bone.
Rosmond  et  al.  [51]  proposed  that  genetic  variation  in
HSD3B1 might lead to an elevation in plasma aldosterone (one
of the mineralocorticoids, which are downstream products of
progestogens),  with  a  resultant  increase  in  intravascular
volume and hypertension, and they did prove the rs6203 silent
substitution  in  exon  4  of  HSD3B1  was  associated  with
elevated blood pressure in a population of Swedish men. Thus,
it is possible that genetic variations in these steroidogenesis
enzyme  genes  might  also  influence  sex  steroids  and  the
pathogenesis  of  steroid-related  diseases.  Our  results  also
support  the  associations  between  genetic  variations  of
steroidogenesis enzyme genes and high myopia.
This current study showed that high-myopia cases have
significantly  higher  levels  of  testosterone  in  both  sexes,
TABLE 5. ANOVA FOR SEX HORMONE LEVELS AMONG STUDY POPULATION, INCLUDING GENE-SEX   INTERACTION.
  Progesterone Estradiol Testosterone
Variables F p-value F p-value F p-value
Univariate
Age 0.12 0.727 1.17 0.280 0.10 0.752
Sex 14.64 <0.001 127.09 <0.001 28.80 <0.001
rs743572 (CYP17A1) 0.20 0.820 0.93 0.339 1.63 0.198
rs6203 (HSD3B1) 0.30 0.743 1.26 0.284 1.59 0.206
rs1047303 (HSD3B1) 0.00 0.996 0.77 0.461 0.67 0.512
rs605059 (HSD17B1) 0.23 0.796 0.85 0.428 0.57 0.566
rs523349 (SRD5A2) 0.30 0.741 0.66 0.517 0.51 0.603
rs10046 (CYP19A1) 0.25 0.783 0.24 0.786 0.23 0.795
Interaction
rs743572 (CYP17A1)*
Sex
0.55 0.580 1.62 0.199 1.25 0.782
rs6203 (HSD3B1)*
Sex
0.16 0.856 0.60 0.547 0.64 0.526
rs1047303 (HSD3B1)*
Sex
0.35 0.555 1.01 0.315 1.08 0.298
rs605059 (HSD17B1)*
Sex
1.50 0.225 3.38 0.035 3.09 0.046
rs523349 (SRD5A2)*
Sex
0.10 0.904 0.57 0.568 0.47 0.624
rs10046 (CYP19A1)*
Sex
0.45 0.640 1.14 0.320 1.14 0.320
               F=The effect of an independent variable on hormone levels after adjustment for all other independent variables.
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associated  with  an  increased  risk  of  high  myopia.
Additionally,  in  males,  serum  levels  of  estradiol  are
significantly  higher  and  serum  levels  of  progesterone  are
significantly lower in the high-myopia group. The possibility
that steroid levels are associated with an increased rate of axial
elongation  requires  further  elucidation  by  a  longitudinal
study. Previously, Balacco et al. [72] reported higher levels of
steroids (testosterone) in high-myopia cases (in excess of −10
D). Plasma cortisol levels have been shown to be lower in
myopia cases than in normal subjects [73], although the results
were not highly significant and the study size was small. In
another case-control study, no significant differences were
noted in serum levels of cortisol, testosterone, or estradiol
between high myopes and non-myopes (p>0.1) [74], but the
study size was also small. The number of subjects for our study
is relatively large, and the results are significant (all p-values
<0.001).  Modulated  by  retinoscleral  signals,  the  scleral
remodeling  mechanism  is  intrinsic  to  myopia  [13].  The
existence of sex steroid receptors in the retina [24,26,28]
makes  an  effect  of  sex  hormones  on  retinoscleral  signals
plausible.
Estrogen has been shown to upregulate MMP-2 and/or
MMP-9  in  human  ocular  cells  [26,45],  and  MMP-2
upregulation was suggested as part of the scleral remodeling
process in myopia development [17,23]. The finding of higher
TABLE 6. GENOTYPES AND SEX HORMONE LEVELS AMONG MALE SUBJECTS
  Progesterone (ng/ml) Estradiol (pg/ml) Testosterone (ng/ml)
Study population Mean Standard deviation Mean Standard
deviation
Mean Standard deviation
rs743572 (CYP17A1)
GG (n=76) 3.12 2.01 24.27 14.44 6.10 1.80
GA (n=156) 3.45 3.88 24.34 14.19 5.75 1.87
AA (n=57) 2.99 1.69 21.55 12.48 5.75 2.16
p-value 0.494 0.358 0.438
rs6203 (HSD3B1)
TT (n=120) 3.48 4.19 23.49 14.38 5.93 1.95
TC (n=133) 3.04 2.09 24.03 13.93 5.74 1.89
CC (n=36) 3.44 1.92 23.76 12.72 5.94 1.86
p-value 0.483 0.967 0.684
rs1047303
(HSD3B1)
AA (n=239) 3.37 3.36 23.86 14.18 5.89 1.84
AC (n=48) 2.75 1.49 23.00 12.86 5.68 2.24
CC (n=2) 3.97 3.01 32.61 6.85 4.34 0.54
p-value 0.454 0.653 0.414
rs605059
(HSD17B1)
GG (n=83) 2.77 1.50 20.50 11.08 5.67 1.72
GA (n=151) 3.42 2.88 24.80 14.21 5.92 2.09
AA (n=55) 3.60 5.00 25.88 16.24 5.91 1.64
p-value 0.214 0.035 0.600
rs523349 (SRD5A2)
GG (n=110) 2.92 1.88 21.63 11.15 5.91 1.93
GC (n=138) 3.58 4.12 25.63 15.84 5.84 1.96
CC (n=41) 3.17 1.38 23.31 13.21 4.70 1.71
p-value 0.217 0.066 0.866
rs10046 (CYP19A1)
AA (n=91) 2.86 1.42 21.35 11.51 5.88 1.88
AG (n=146) 3.52 3.83 25.50 14.50 5.85 1.90
GG (n=52) 3.29 3.07 23.15 15.64 5.77 2.00
p-value 0.249 0.064 0.960
p-values were adjusted by age.
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our hypothesis that differential sex hormone levels may play
a role in myopia pathogenesis by regulating MMP-2.
Because  steroidogenesis  enzymes  catalyze  the
biosynthesis  of  sex  hormones,  we  examined  whether
polymorphisms of these enzymes influence the serum levels
of  sex  hormones.  Our  data  suggested  that  for  males,
rs605059 (HSD17B1) A allele is associated with a significant
increase in the level of estradiol and a non-significant increase
in the level of testosterone; for females, it is associated with
a  non-significant  decrease  in  the  level  of  estradiol  and  a
significant decrease in the level of testosterone. This sexual
dimorphism could be the result of a sex-gene interaction we
demonstrated by ANOVA analysis (Table 5), although these
results of female subjects should be interpreted with caution
because of limitations to the present association study. The
effect of polymorphisms in estrogen-metabolizing genes on
circulating  estrogen  levels  would  be  most  pronounced  in
women with no other sources of estrogens because peripheral
conversion of androgens in the adipose tissue or hormone
replacement therapy (HRT) may mask the genetic effect. In
addition,  fluctuations  in  progesterone  and  estradiol  levels
TABLE 7. GENOTYPES AND SEX HORMONE LEVELS AMONG FEMALE SUBJECTS.
 
Progesterone (ng/ml) Estradiol (pg/ml) Testosterone (ng/ml)
Study population Mean Standard Deviation Mean Standard
Deviation
Mean Standard Deviation
rs743572
(CYP17A1)
GG (n=98) 5.33 7.13 42.98 28.69 1.41 0.86
GA (n=128) 5.98 7.30 50.53 34.26 1.64 1.35
AA (n=48) 5.71 5.22 44.39 28.08 1.67 1.07
p-value 0.780 0.171 0.257
rs6203 (HSD3B1)
TT (n=108) 5.70 7.40 44.16 30.31 1.71 1.38
TC (n=138) 5.59 6.17 48.74 33.11 1.48 0.98
CC (n=28) 6.26 8.43 46.95 27.11 1.41 0.85
p-value 0.799 0.386 0.361
rs1047303
(HSD3B1)
AA (n=236) 5.66 6.80 47.27 30.56 1.58 1.14
AC (n=38) 5.97 7.63 43.57 36.64 1.43 1.21
p-value 0.666 0.569 0.484
rs605059
(HSD17B1)
GG (n=80) 6.34 6.65 50.64 34.79 1.83 1.44
GA (n=136) 5.54 7.27 47.43 31.87 1.44 0.94
AA (n=58) 5.18 6.42 39.82 23.97 1.48 1.10
p-value 0.425 0.114 0.027
rs523349
(SRD5A2)
GG (n=86) 5.53 7.16 48.03 30.78 1.52 1.02
GC (n=132) 5.94 7.48 47.59 34.06 1.61 1.35
CC (n=56) 5.41 4.90 42.83 25.56 1.49 0.78
p-value 0.977 0.612 0.846
rs10046
(CYP19A1)
AA (n=76) 6.13 8.02 50.83 36.93 1.50 1.00
AG (n=143) 5.37 6.25 45.34 29.38 1.60 1.16
GG (n=55) 5.97 6.95 44.79 28.19 1.56 1.32
p-value 0.843 0.552 0.546
p-values were adjusted by age.
Molecular Vision 2011; 17:2297-2310 <http://www.molvis.org/molvis/v17/a250> © 2011 Molecular Vision
2305during  the  menstrual  cycle  or  pregnancy  may  obscure  a
modest genetic effect. Hence, a future study with a larger
sample size and more considerable lifestyle information will
help match controls to cases regarding various confounders—
such  as  age,  body  mass  index  (BMI),  pregnancy  or
menopausal status, HRT usage, day of period, time of day,
and  fasting  status  at  blood  draw—and  determine  these
associations  in  females.  Evidence  proves  that  sexual
dimorphism of the muscarinic system exists in the human
brain  and  bladder  [75-79].  In  rat  models,  sex  steroids
selectively modulate muscarinic receptors in certain brain
tissues  (e.g.,  hypothalamus,  adenohypophysis,  superior
cervical  ganglia,  or  anterior  pituitary  gland)  in  a  region-
specific manner but not in the retina [80-85]. The muscarinic
receptors and hormone receptors might be in different steps
of a common pathway in myopia. Previous studies that have
examined  the  rs605059  (HSD17B1)  variant  in  relation  to
estrogens found no association [86-88]. The enzymes 17 beta-
hydroxysteroid dehydrogenase 1 (HSD17B1) and 17 beta-
hydroxysteroid dehydrogenase 2 (HSD17B2) are responsible
for the reduction and oxidation of estrogens to more- and less-
active forms, respectively. HSD17B1 is responsible for the
reduction of estrone to estradiol, the more bioactive estrogen;
HSD17B2  is  responsible  for  the  oxidation  of  estradiol  to
estrone. In addition to activating estrone to estradiol, human
HSD17B1  enhances  androgen  activity  in  vivo  [89].  The
functional significance of rs605059 (HSD17B1) is unclear,
but  it  appears  to  have  little  effect  on  the  catalytic  or
immunological properties of this enzyme [90] and is indicated
by sequence homology analysis (though with low confidence)
that it is unlikely to affect function [91].
We observed associations between certain combinations
of polymorphisms at steroidogenesis enzyme genes (rs6203
[HSD3B1], rs10046 [CYP19A1], and sex) and high-myopia
risk; meanwhile, there is evidence of correlations between
rs605059  (HSD17B1)–sex  interaction  and  sex  hormone
levels. Sex hormones may play only a modulating rather than
mediating role in the formation of high myopia; thus, the
genotype associations with hormone levels and high-myopia
traits are not parallel, and the small genetic effect of genotype-
disease  association  cannot  be  detected  unless  a  stratified
synergistic  association  analysis  is  applied.  The  complex
TABLE 8. COMPARISON OF ALLELE FREQUENCIES BETWEEN TAIWANESE AND OTHER POPULATIONS.
  Study population
 Gene Allele Taiwan
(n=280)
CEU (n=116) YRI (n=118) HCB (n=90) JPT (n=88)
rs743572 (CYP17A1) A 0.427 0.603 0.729 0.456 0.625
  G 0.573 0.397 0.271 0.544 0.375
  p-value   <0.001 <0.001 0.498 <0.001
    Taiwan (n=280) CEU (n=120) YRI (n=120) HCB (n=90) JPT (n=88)
rs6203 (HSD3B1) C 0.359 0.608 1.000 0.322 0.375
  T 0.641 0.392 0.000 0.678 0.625
  p-value   <0.001 <0001 0.369 0.699
    Taiwan (n=280) CEU (n=120) YRI (n=120) HCB (n=90) JPT (n=88)
rs1047303 (HSD3B1) A 0.925 0.992 0.992 0.900 0.898
  C 0.075 0.008 0.008 0.100 0.102
  p-value   <0.001 <0.001 0.285 0.249
    Taiwan (n=280) CEPH
(n=184)
YRI (NA) HCB (NA) JPT (NA)
rs605059 (HSD17B1) A 0.466 0.730      
  G 0.534 0.270      
  p-value   <0.001      
    Taiwan (n=280) CEU (n=120) YRI (n=120) HCB (n=90) JPT (n=86)
rs523349 (SRD5A2) C 0.416 0.808 0.775 0.522 0.640
  G 0.584 0.192 0.225 0.478 0.360
  p-value   <0.001 <0.001 0.013 <0.001
    Taiwan (n=280) CEU (n=110) YRI (n=120) HCB (n=90) JPT (n=90)
rs10046 (CYP19A1) C 0.557 0.445 0.825 0.411 0.578
  T 0.443 0.555 0.175 0.589 0.422
  p-value   0.005 <0.001 <0.001 0.627
         CEU: Utah residents with Northern and Western European ancestry from the CEPH collection; YRI: Yoruba in Ibadan, Nigeria;
         HCB: Han Chinese in Beijing, China; JPT: Japanese in Tokyo, Japan; CEPH: Centre d’Etude du Polymorphisme Human
         pedigrees; NA: not available. p-values were calculated by pairwise comparisons of allele frequencies between the Taiwanese
         population and other populations.
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2306underlying  genetic  mechanism,  especially  in  complex
diseases,  warrants  consideration  of  environment-gene  and
gene-gene interactions. Our study did clearly reveal that a sex-
gene interaction plays a significant role in sex hormone levels
and high-myopia traits as well. A larger sample size and more
comprehensive  confounder  controlling  will  further  help
elucidate the associations.
In conclusion, these findings reflect the unique genetic
characteristics  of  the  Han  Chinese  population.  We  found
significant correlations between sex steroid levels and high
myopia,  and  the  synergistic  interaction  of  sex  and
steroidogenesis enzyme genes might confer susceptibility to
high myopia and influence sex steroid levels. Further studies
are required to confirm this relationship. Sex-gene interaction
is crucial for understanding sex hormone metabolism and
possible high-myopia risk.
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